Impact of targeted therapies on the risk of cardiovascular events in patients with psoriasis and psoriatic arthritis: A systematic review and aggregate data meta-analysis of randomized controlled trials.
Ruyi CaiYinji JinBeidi ChenJinxia ZhaoJiayu ZhaiLin ZengRong MuPublished in: International journal of rheumatic diseases (2023)
Current targeted therapies are not associated with the risk of CVEs. Based on the existing evidence, we reported here that a dosage reduction of targeted therapies was not recommended.